TABLE OF CONTENTS 1 Research Methodology and Statistical Scope 1.1 Market Definition and Statistical Scope of Antihypertensive 1.2 Key Market Segments 1.2.1 Antihypertensive Segment by Type 1.2.2 Antihypertensive Segment by Application 1.3 Methodology & Sources of Information 1.3.1 Research Methodology 1.3.2 Research Process 1.3.3 Market Breakdown and Data Triangulation 1.3.4 Base Year 1.3.5 Report Assumptions & Caveats 2 Antihypertensive Market Overview 2.1 Global Market Overview 2.1.1 Global Antihypertensive Market Size (M USD) Estimates and Forecasts (2017-2028) 2.1.2 Global Antihypertensive Sales Estimates and Forecasts (2017-2028) 2.2 Market Segment Executive Summary 2.3 Global Market Size by Region 3 Antihypertensive Market Competitive Landscape 3.1 Global Antihypertensive Sales by Manufacturers (2017-2022) 3.2 Global Antihypertensive Revenue Market Share by Manufacturers (2017-2022) 3.3 Antihypertensive Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4 Global Antihypertensive Average Price by Manufacturers (2017-2022) 3.5 Manufacturers Antihypertensive Sales Sites, Area Served, Product Type 3.6 Antihypertensive Market Competitive Situation and Trends 3.6.1 Antihypertensive Market Concentration Rate 3.6.2 Global 5 and 10 Largest Antihypertensive Players Market Share by Revenue 3.6.3 Mergers & Acquisitions, Expansion 4 Antihypertensive Industry Chain Analysis 4.1 Antihypertensive Industry Chain Analysis 4.2 Market Overview and Market Concentration Analysis of Key Raw Materials 4.3 Midstream Market Analysis 4.4 Downstream Customer Analysis 5 The Development and Dynamics of Antihypertensive Market 5.1 Key Development Trends 5.2 Driving Factors 5.3 Market Challenges 5.4 Market Restraints 5.5 Industry News 5.5.1 New Product Developments 5.5.2 Mergers & Acquisitions 5.5.3 Expansions 5.5.4 Collaboration/Supply Contracts 5.6 Industry Policies 6 Antihypertensive Market Segmentation by Type 6.1 Evaluation Matrix of Segment Market Development Potential (Type) 6.2 Global Antihypertensive Sales Market Share by Type (2017-2022) 6.3 Global Antihypertensive Market Size Market Share by Type (2017-2022) 6.4 Global Antihypertensive Price by Type (2017-2022) 7 Antihypertensive Market Segmentation by Application 7.1 Evaluation Matrix of Segment Market Development Potential (Application) 7.2 Global Antihypertensive Market Sales by Application (2017-2022) 7.3 Global Antihypertensive Market Size (M USD) by Application (2017-2022) 7.4 Global Antihypertensive Sales Growth Rate by Application (2017-2022) 8 Antihypertensive Market Segmentation by Region 8.1 Global Antihypertensive Sales by Region 8.1.1 Global Antihypertensive Sales by Region 8.1.2 Global Antihypertensive Sales Market Share by Region 8.2 North America 8.2.1 North America Antihypertensive Sales by Country 8.2.2 U.S. 8.2.3 Canada 8.2.4 Mexico 8.3 Europe 8.3.1 Europe Antihypertensive Sales by Country 8.3.2 Germany 8.3.3 France 8.3.4 U.K. 8.3.5 Italy 8.3.6 Russia 8.4 Asia Pacific 8.4.1 Asia Pacific Antihypertensive Sales by Region 8.4.2 China 8.4.3 Japan 8.4.4 South Korea 8.4.5 India 8.4.6 Southeast Asia 8.5 South America 8.5.1 South America Antihypertensive Sales by Country 8.5.2 Brazil 8.5.3 Argentina 8.5.4 Columbia 8.6 Middle East and Africa 8.6.1 Middle East and Africa Antihypertensive Sales by Region 8.6.2 Saudi Arabia 8.6.3 UAE 8.6.4 Egypt 8.6.5 Nigeria 8.6.6 South Africa 9 Key Companies Profiled 9.1 Pfizer 9.1.1 Pfizer Antihypertensive Basic Information 9.1.2 Pfizer Antihypertensive Product Overview 9.1.3 Pfizer Antihypertensive Product Market Performance 9.1.4 Pfizer Business Overview 9.1.5 Pfizer Antihypertensive SWOT Analysis 9.1.6 Pfizer Recent Developments 9.2 Norvatis 9.2.1 Norvatis Antihypertensive Basic Information 9.2.2 Norvatis Antihypertensive Product Overview 9.2.3 Norvatis Antihypertensive Product Market Performance 9.2.4 Norvatis Business Overview 9.2.5 Norvatis Antihypertensive SWOT Analysis 9.2.6 Norvatis Recent Developments 9.3 Merck and Co. 9.3.1 Merck and Co. Antihypertensive Basic Information 9.3.2 Merck and Co. Antihypertensive Product Overview 9.3.3 Merck and Co. Antihypertensive Product Market Performance 9.3.4 Merck and Co. Business Overview 9.3.5 Merck and Co. Antihypertensive SWOT Analysis 9.3.6 Merck and Co. Recent Developments 9.4 Sanofi 9.4.1 Sanofi Antihypertensive Basic Information 9.4.2 Sanofi Antihypertensive Product Overview 9.4.3 Sanofi Antihypertensive Product Market Performance 9.4.4 Sanofi Business Overview 9.4.5 Sanofi Antihypertensive SWOT Analysis 9.4.6 Sanofi Recent Developments 9.5 AstraZeneca 9.5.1 AstraZeneca Antihypertensive Basic Information 9.5.2 AstraZeneca Antihypertensive Product Overview 9.5.3 AstraZeneca Antihypertensive Product Market Performance 9.5.4 AstraZeneca Business Overview 9.5.5 AstraZeneca Antihypertensive SWOT Analysis 9.5.6 AstraZeneca Recent Developments 9.6 GSK 9.6.1 GSK Antihypertensive Basic Information 9.6.2 GSK Antihypertensive Product Overview 9.6.3 GSK Antihypertensive Product Market Performance 9.6.4 GSK Business Overview 9.6.5 GSK Recent Developments 9.7 Daiichi-Sankyo 9.7.1 Daiichi-Sankyo Antihypertensive Basic Information 9.7.2 Daiichi-Sankyo Antihypertensive Product Overview 9.7.3 Daiichi-Sankyo Antihypertensive Product Market Performance 9.7.4 Daiichi-Sankyo Business Overview 9.7.5 Daiichi-Sankyo Recent Developments 9.8 Boehringer-Ingelheim 9.8.1 Boehringer-Ingelheim Antihypertensive Basic Information 9.8.2 Boehringer-Ingelheim Antihypertensive Product Overview 9.8.3 Boehringer-Ingelheim Antihypertensive Product Market Performance 9.8.4 Boehringer-Ingelheim Business Overview 9.8.5 Boehringer-Ingelheim Recent Developments 9.9 Bayer 9.9.1 Bayer Antihypertensive Basic Information 9.9.2 Bayer Antihypertensive Product Overview 9.9.3 Bayer Antihypertensive Product Market Performance 9.9.4 Bayer Business Overview 9.9.5 Bayer Recent Developments 9.10 Johnson and Johnson 9.10.1 Johnson and Johnson Antihypertensive Basic Information 9.10.2 Johnson and Johnson Antihypertensive Product Overview 9.10.3 Johnson and Johnson Antihypertensive Product Market Performance 9.10.4 Johnson and Johnson Business Overview 9.10.5 Johnson and Johnson Recent Developments 9.11 Bristol-Myers Squibb 9.11.1 Bristol-Myers Squibb Antihypertensive Basic Information 9.11.2 Bristol-Myers Squibb Antihypertensive Product Overview 9.11.3 Bristol-Myers Squibb Antihypertensive Product Market Performance 9.11.4 Bristol-Myers Squibb Business Overview 9.11.5 Bristol-Myers Squibb Recent Developments 9.12 Tekeda 9.12.1 Tekeda Antihypertensive Basic Information 9.12.2 Tekeda Antihypertensive Product Overview 9.12.3 Tekeda Antihypertensive Product Market Performance 9.12.4 Tekeda Business Overview 9.12.5 Tekeda Recent Developments 9.13 Ranbaxy Laboratories 9.13.1 Ranbaxy Laboratories Antihypertensive Basic Information 9.13.2 Ranbaxy Laboratories Antihypertensive Product Overview 9.13.3 Ranbaxy Laboratories Antihypertensive Product Market Performance 9.13.4 Ranbaxy Laboratories Business Overview 9.13.5 Ranbaxy Laboratories Recent Developments 9.14 Shihuida Pharm 9.14.1 Shihuida Pharm Antihypertensive Basic Information 9.14.2 Shihuida Pharm Antihypertensive Product Overview 9.14.3 Shihuida Pharm Antihypertensive Product Market Performance 9.14.4 Shihuida Pharm Business Overview 9.14.5 Shihuida Pharm Recent Developments 9.15 Second Pharmaceutical 9.15.1 Second Pharmaceutical Antihypertensive Basic Information 9.15.2 Second Pharmaceutical Antihypertensive Product Overview 9.15.3 Second Pharmaceutical Antihypertensive Product Market Performance 9.15.4 Second Pharmaceutical Business Overview 9.15.5 Second Pharmaceutical Recent Developments 9.16 Lupin Limited. 9.16.1 Lupin Limited. Antihypertensive Basic Information 9.16.2 Lupin Limited. Antihypertensive Product Overview 9.16.3 Lupin Limited. Antihypertensive Product Market Performance 9.16.4 Lupin Limited. Business Overview 9.16.5 Lupin Limited. Recent Developments 9.17 Yangtze River Pharmaceutical 9.17.1 Yangtze River Pharmaceutical Antihypertensive Basic Information 9.17.2 Yangtze River Pharmaceutical Antihypertensive Product Overview 9.17.3 Yangtze River Pharmaceutical Antihypertensive Product Market Performance 9.17.4 Yangtze River Pharmaceutical Business Overview 9.17.5 Yangtze River Pharmaceutical Recent Developments 9.18 Hengrui Medicine 9.18.1 Hengrui Medicine Antihypertensive Basic Information 9.18.2 Hengrui Medicine Antihypertensive Product Overview 9.18.3 Hengrui Medicine Antihypertensive Product Market Performance 9.18.4 Hengrui Medicine Business Overview 9.18.5 Hengrui Medicine Recent Developments 9.19 Qilu Pharmaceutical 9.19.1 Qilu Pharmaceutical Antihypertensive Basic Information 9.19.2 Qilu Pharmaceutical Antihypertensive Product Overview 9.19.3 Qilu Pharmaceutical Antihypertensive Product Market Performance 9.19.4 Qilu Pharmaceutical Business Overview 9.19.5 Qilu Pharmaceutical Recent Developments 9.20 HUALON 9.20.1 HUALON Antihypertensive Basic Information 9.20.2 HUALON Antihypertensive Product Overview 9.20.3 HUALON Antihypertensive Product Market Performance 9.20.4 HUALON Business Overview 9.20.5 HUALON Recent Developments 9.21 Dawnrays 9.21.1 Dawnrays Antihypertensive Basic Information 9.21.2 Dawnrays Antihypertensive Product Overview 9.21.3 Dawnrays Antihypertensive Product Market Performance 9.21.4 Dawnrays Business Overview 9.21.5 Dawnrays Recent Developments 9.22 HISUN Pharmceutical 9.22.1 HISUN Pharmceutical Antihypertensive Basic Information 9.22.2 HISUN Pharmceutical Antihypertensive Product Overview 9.22.3 HISUN Pharmceutical Antihypertensive Product Market Performance 9.22.4 HISUN Pharmceutical Business Overview 9.22.5 HISUN Pharmceutical Recent Developments 10 Antihypertensive Market Forecast by Region 10.1 Global Antihypertensive Market Size Forecast 10.2 Global Antihypertensive Market Forecast by Region 10.2.1 North America Market Size Forecast by Country 10.2.2 Europe Antihypertensive Market Size Forecast by Country 10.2.3 Asia Pacific Antihypertensive Market Size Forecast by Region 10.2.4 South America Antihypertensive Market Size Forecast by Country 10.2.5 Middle East and Africa Forecasted Consumption of Antihypertensive by Country 11 Forecast Market by Type and by Application (2022-2028) 11.1 Global Antihypertensive Market Forecast by Type (2022-2028) 11.1.1 Global Forecasted Sales of Antihypertensive by Type (2022-2028) 11.1.2 Global Antihypertensive Market Size Forecast by Type (2022-2028) 11.1.3 Global Forecasted Price of Antihypertensive by Type (2022-2028) 11.2 Global Antihypertensive Market Forecast by Application (2022-2028) 11.2.1 Global Antihypertensive Sales (K Units) Forecast by Application 11.2.2 Global Antihypertensive Market Size (M USD) Forecast by Application (2022-2028) 12 Conclusion and Key Findings

LIST OF TABLES Table 1. Introduction of the Type Table 2. Introduction of the Application Table 3. Market Size (M USD) Segment Executive Summary Table 4. Antihypertensive Market Size (M USD) Comparison by Region (M USD) Table 5. Global Antihypertensive Sales (K Units) by Manufacturers (2017-2022) Table 6. Global Antihypertensive Sales Market Share by Manufacturers (2017-2022) Table 7. Global Antihypertensive Revenue (M USD) by Manufacturers (2017-2022) Table 8. Global Antihypertensive Revenue Share by Manufacturers (2017-2022) Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antihypertensive as of 2021) Table 10. Global Market Antihypertensive Average Price (USD/Unit) of Key Manufacturers (2017-2022) Table 11. Manufacturers Antihypertensive Sales Sites and Area Served Table 12. Manufacturers Antihypertensive Product Type Table 13. Global Antihypertensive Manufacturers Market Concentration Ratio (CR5 and HHI) Table 14. Mergers & Acquisitions, Expansion Plans Table 15. Industry Chain Map of Antihypertensive Table 16. Raw Materials Table 17. Midstream Market Analysis Table 18. Downstream Customer Analysis Table 19. Key Development Trends Table 20. Driving Factors Table 21. Antihypertensive Market Challenges Table 22. Market Restraints Table 23. Global Antihypertensive Sales by Type (K Units) Table 24. Global Antihypertensive Market Size by Type (M USD) Table 25. Global Antihypertensive Sales (K Units) by Type (2017-2022) Table 26. Global Antihypertensive Sales Market Share by Type (2017-2022) Table 27. Global Antihypertensive Market Size (M USD) by Type (2017-2022) Table 28. Global Antihypertensive Market Size Share by Type (2017-2022) Table 29. Global Antihypertensive Price (USD/Unit) by Type (2017-2022) Table 30. Global Antihypertensive Sales (K Units) by Application Table 31. Global Antihypertensive Market Size by Application Table 32. Global Antihypertensive Sales by Application (2017-2022) & (K Units) Table 33. Global Antihypertensive Sales Market Share by Application (2017-2022) Table 34. Global Antihypertensive Sales by Application (2017-2022) & (M USD) Table 35. Global Antihypertensive Market Share by Application (2017-2022) Table 36. Global Antihypertensive Sales Growth Rate by Application (2017-2022) Table 37. Global Antihypertensive Sales by Region (2017-2022) & (K Units) Table 38. Global Antihypertensive Sales Market Share by Region (2017-2022) Table 39. North America Antihypertensive Sales by Country (2017-2022) & (K Units) Table 40. Europe Antihypertensive Sales by Country (2017-2022) & (K Units) Table 41. Asia Pacific Antihypertensive Sales by Region (2017-2022) & (K Units) Table 42. South America Antihypertensive Sales by Country (2017-2022) & (K Units) Table 43. Middle East and Africa Antihypertensive Sales by Region (2017-2022) & (K Units) Table 44. Pfizer Antihypertensive Basic Information Table 45. Pfizer Antihypertensive Product Overview Table 46. Pfizer Antihypertensive Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 47. Pfizer Business Overview Table 48. Pfizer Antihypertensive SWOT Analysis Table 49. Pfizer Recent Developments Table 50. Norvatis Antihypertensive Basic Information Table 51. Norvatis Antihypertensive Product Overview Table 52. Norvatis Antihypertensive Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 53. Norvatis Business Overview Table 54. Norvatis Antihypertensive SWOT Analysis Table 55. Norvatis Recent Developments Table 56. Merck and Co. Antihypertensive Basic Information Table 57. Merck and Co. Antihypertensive Product Overview Table 58. Merck and Co. Antihypertensive Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 59. Merck and Co. Business Overview Table 60. Merck and Co. Antihypertensive SWOT Analysis Table 61. Merck and Co. Recent Developments Table 62. Sanofi Antihypertensive Basic Information Table 63. Sanofi Antihypertensive Product Overview Table 64. Sanofi Antihypertensive Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 65. Sanofi Business Overview Table 66. Sanofi Antihypertensive SWOT Analysis Table 67. Sanofi Recent Developments Table 68. AstraZeneca Antihypertensive Basic Information Table 69. AstraZeneca Antihypertensive Product Overview Table 70. AstraZeneca Antihypertensive Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 71. AstraZeneca Business Overview Table 72. AstraZeneca Antihypertensive SWOT Analysis Table 73. AstraZeneca Recent Developments Table 74. GSK Antihypertensive Basic Information Table 75. GSK Antihypertensive Product Overview Table 76. GSK Antihypertensive Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 77. GSK Business Overview Table 78. GSK Recent Developments Table 79. Daiichi-Sankyo Antihypertensive Basic Information Table 80. Daiichi-Sankyo Antihypertensive Product Overview Table 81. Daiichi-Sankyo Antihypertensive Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 82. Daiichi-Sankyo Business Overview Table 83. Daiichi-Sankyo Recent Developments Table 84. Boehringer-Ingelheim Antihypertensive Basic Information Table 85. Boehringer-Ingelheim Antihypertensive Product Overview Table 86. Boehringer-Ingelheim Antihypertensive Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 87. Boehringer-Ingelheim Business Overview Table 88. Boehringer-Ingelheim Recent Developments Table 89. Bayer Antihypertensive Basic Information Table 90. Bayer Antihypertensive Product Overview Table 91. Bayer Antihypertensive Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 92. Bayer Business Overview Table 93. Bayer Recent Developments Table 94. Johnson and Johnson Antihypertensive Basic Information Table 95. Johnson and Johnson Antihypertensive Product Overview Table 96. Johnson and Johnson Antihypertensive Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 97. Johnson and Johnson Business Overview Table 98. Johnson and Johnson Recent Developments Table 99. Bristol-Myers Squibb Antihypertensive Basic Information Table 100. Bristol-Myers Squibb Antihypertensive Product Overview Table 101. Bristol-Myers Squibb Antihypertensive Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 102. Bristol-Myers Squibb Business Overview Table 103. Bristol-Myers Squibb Recent Developments Table 104. Tekeda Antihypertensive Basic Information Table 105. Tekeda Antihypertensive Product Overview Table 106. Tekeda Antihypertensive Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 107. Tekeda Business Overview Table 108. Tekeda Recent Developments Table 109. Ranbaxy Laboratories Antihypertensive Basic Information Table 110. Ranbaxy Laboratories Antihypertensive Product Overview Table 111. Ranbaxy Laboratories Antihypertensive Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 112. Ranbaxy Laboratories Business Overview Table 113. Ranbaxy Laboratories Recent Developments Table 114. Shihuida Pharm Antihypertensive Basic Information Table 115. Shihuida Pharm Antihypertensive Product Overview Table 116. Shihuida Pharm Antihypertensive Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 117. Shihuida Pharm Business Overview Table 118. Shihuida Pharm Recent Developments Table 119. Second Pharmaceutical Antihypertensive Basic Information Table 120. Second Pharmaceutical Antihypertensive Product Overview Table 121. Second Pharmaceutical Antihypertensive Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 122. Second Pharmaceutical Business Overview Table 123. Second Pharmaceutical Recent Developments Table 124. Lupin Limited. Antihypertensive Basic Information Table 125. Lupin Limited. Antihypertensive Product Overview Table 126. Lupin Limited. Antihypertensive Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 127. Lupin Limited. Business Overview Table 128. Lupin Limited. Recent Developments Table 129. Yangtze River Pharmaceutical Antihypertensive Basic Information Table 130. Yangtze River Pharmaceutical Antihypertensive Product Overview Table 131. Yangtze River Pharmaceutical Antihypertensive Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 132. Yangtze River Pharmaceutical Business Overview Table 133. Yangtze River Pharmaceutical Recent Developments Table 134. Hengrui Medicine Antihypertensive Basic Information Table 135. Hengrui Medicine Antihypertensive Product Overview Table 136. Hengrui Medicine Antihypertensive Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 137. Hengrui Medicine Business Overview Table 138. Hengrui Medicine Recent Developments Table 139. Qilu Pharmaceutical Antihypertensive Basic Information Table 140. Qilu Pharmaceutical Antihypertensive Product Overview Table 141. Qilu Pharmaceutical Antihypertensive Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 142. Qilu Pharmaceutical Business Overview Table 143. Qilu Pharmaceutical Recent Developments Table 144. HUALON Antihypertensive Basic Information Table 145. HUALON Antihypertensive Product Overview Table 146. HUALON Antihypertensive Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 147. HUALON Business Overview Table 148. HUALON Recent Developments Table 149. Dawnrays Antihypertensive Basic Information Table 150. Dawnrays Antihypertensive Product Overview Table 151. Dawnrays Antihypertensive Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 152. Dawnrays Business Overview Table 153. Dawnrays Recent Developments Table 154. HISUN Pharmceutical Antihypertensive Basic Information Table 155. HISUN Pharmceutical Antihypertensive Product Overview Table 156. HISUN Pharmceutical Antihypertensive Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 157. HISUN Pharmceutical Business Overview Table 158. HISUN Pharmceutical Recent Developments Table 159. Global Antihypertensive Sales Forecast by Region (K Units) Table 160. Global Antihypertensive Market Size Forecast by Region (M USD) Table 161. North America Antihypertensive Sales Forecast by Country (2022-2028) & (K Units) Table 162. North America Antihypertensive Market Size Forecast by Country (2022-2028) & (M USD) Table 163. Europe Antihypertensive Sales Forecast by Country (2022-2028) & (K Units) Table 164. Europe Antihypertensive Market Size Forecast by Country (2022-2028) & (M USD) Table 165. Asia Pacific Antihypertensive Sales Forecast by Region (2022-2028) & (K Units) Table 166. Asia Pacific Antihypertensive Market Size Forecast by Region (2022-2028) & (M USD) Table 167. South America Antihypertensive Sales Forecast by Country (2022-2028) & (K Units) Table 168. South America Antihypertensive Market Size Forecast by Country (2022-2028) & (M USD) Table 169. Middle East and Africa Antihypertensive Consumption Forecast by Country (2022-2028) & (Units) Table 170. Middle East and Africa Antihypertensive Market Size Forecast by Country (2022-2028) & (M USD) Table 171. Global Antihypertensive Sales Forecast by Type (2022-2028) & (K Units) Table 172. Global Antihypertensive Market Size Forecast by Type (2022-2028) & (M USD) Table 173. Global Antihypertensive Price Forecast by Type (2022-2028) & (USD/Unit) Table 174. Global Antihypertensive Sales (K Units) Forecast by Application (2022-2028) Table 175. Global Antihypertensive Market Size Forecast by Application (2022-2028) & (M USD) LIST OF FIGURES Figure 1. Product Picture of Antihypertensive Figure 2. Data Triangulation Figure 3. Key Caveats Figure 4. Global Antihypertensive Market Size (M USD), 2017-2028 Figure 5. Global Antihypertensive Market Size (M USD) (2017-2028) Figure 6. Global Antihypertensive Sales (K Units) & (2017-2028) Figure 7. Evaluation Matrix of Segment Market Development Potential (Type) Figure 8. Evaluation Matrix of Segment Market Development Potential (Application) Figure 9. Evaluation Matrix of Regional Market Development Potential Figure 10. Antihypertensive Market Size (M USD) by Country (M USD) Figure 11. Antihypertensive Sales Share by Manufacturers in 2020 Figure 12. Global Antihypertensive Revenue Share by Manufacturers in 2020 Figure 13. Antihypertensive Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021 Figure 14. Global Market Antihypertensive Average Price (USD/Unit) of Key Manufacturers in 2020 Figure 15. The Global 5 and 10 Largest Players: Market Share by Antihypertensive Revenue in 2021 Figure 16. Evaluation Matrix of Segment Market Development Potential (Type) Figure 17. Global Antihypertensive Market Share by Type Figure 18. Sales Market Share of Antihypertensive by Type (2017-2022) Figure 19. Sales Market Share of Antihypertensive by Type in 2021 Figure 20. Market Size Share of Antihypertensive by Type (2017-2022) Figure 21. Market Size Market Share of Antihypertensive by Type in 2020 Figure 22. Evaluation Matrix of Segment Market Development Potential (Application) Figure 23. Global Antihypertensive Market Share by Application Figure 24. Global Antihypertensive Sales Market Share by Application (2017-2022) Figure 25. Global Antihypertensive Sales Market Share by Application in 2021 Figure 26. Global Antihypertensive Market Share by Application (2017-2022) Figure 27. Global Antihypertensive Market Share by Application in 2020 Figure 28. Global Antihypertensive Sales Growth Rate by Application (2017-2022) Figure 29. Global Antihypertensive Sales Market Share by Region (2017-2022) Figure 30. North America Antihypertensive Sales and Growth Rate (2017-2022) & (K Units) Figure 31. North America Antihypertensive Sales Market Share by Country in 2020 Figure 32. U.S. Antihypertensive Sales and Growth Rate (2017-2022) & (K Units) Figure 33. Canada Antihypertensive Sales (K Units) and Growth Rate (2017-2022) Figure 34. Mexico Antihypertensive Sales (Units) and Growth Rate (2017-2022) Figure 35. Europe Antihypertensive Sales and Growth Rate (2017-2022) & (K Units) Figure 36. Europe Antihypertensive Sales Market Share by Country in 2020 Figure 37. Germany Antihypertensive Sales and Growth Rate (2017-2022) & (K Units) Figure 38. France Antihypertensive Sales and Growth Rate (2017-2022) & (K Units) Figure 39. U.K. Antihypertensive Sales and Growth Rate (2017-2022) & (K Units) Figure 40. Italy Antihypertensive Sales and Growth Rate (2017-2022) & (K Units) Figure 41. Russia Antihypertensive Sales and Growth Rate (2017-2022) & (K Units) Figure 42. Asia Pacific Antihypertensive Sales and Growth Rate (K Units) Figure 43. Asia Pacific Antihypertensive Sales Market Share by Region in 2020 Figure 44. China Antihypertensive Sales and Growth Rate (2017-2022) & (K Units) Figure 45. Japan Antihypertensive Sales and Growth Rate (2017-2022) & (K Units) Figure 46. South Korea Antihypertensive Sales and Growth Rate (2017-2022) & (K Units) Figure 47. India Antihypertensive Sales and Growth Rate (2017-2022) & (K Units) Figure 48. Southeast Asia Antihypertensive Sales and Growth Rate (2017-2022) & (K Units) Figure 49. South America Antihypertensive Sales and Growth Rate (K Units) Figure 50. South America Antihypertensive Sales Market Share by Country in 2020 Figure 51. Brazil Antihypertensive Sales and Growth Rate (2017-2022) & (K Units) Figure 52. Argentina Antihypertensive Sales and Growth Rate (2017-2022) & (K Units) Figure 53. Columbia Antihypertensive Sales and Growth Rate (2017-2022) & (K Units) Figure 54. Middle East and Africa Antihypertensive Sales and Growth Rate (K Units) Figure 55. Middle East and Africa Antihypertensive Sales Market Share by Region in 2020 Figure 56. Saudi Arabia Antihypertensive Sales and Growth Rate (2017-2022) & (K Units) Figure 57. UAE Antihypertensive Sales and Growth Rate (2017-2022) & (K Units) Figure 58. Egypt Antihypertensive Sales and Growth Rate (2017-2022) & (K Units) Figure 59. Nigeria Antihypertensive Sales and Growth Rate (2017-2022) & (K Units) Figure 60. South Africa Antihypertensive Sales and Growth Rate (2017-2022) & (K Units) Figure 61. Global Antihypertensive Sales Forecast by Volume (2017-2028) & (K Units) Figure 62. Global Antihypertensive Market Size Forecast by Value (2017-2028) & (M USD) Figure 63. Global Antihypertensive Sales Market Share Forecast by Type (2022-2028) Figure 64. Global Antihypertensive Market Share Forecast by Type (2022-2028) Figure 65. Global Antihypertensive Sales Forecast by Application (2022-2028) Figure 66. Global Antihypertensive Market Share Forecast by Application (2022-2028)

•Pfizer •Norvatis •Merck and Co. •Sanofi •AstraZeneca •GSK •Daiichi-Sankyo •Boehringer-Ingelheim •Bayer •Johnson and Johnson •Bristol-Myers Squibb •Tekeda •Ranbaxy Laboratories •Shihuida Pharm •Second Pharmaceutical •Lupin Limited. •Yangtze River Pharmaceutical •Hengrui Medicine •Qilu Pharmaceutical •HUALON •Dawnrays •HISUN Pharmceutical